Ara
Toplam kayıt 11, listelenen: 1-10
Geographical Variation In Therapy For Bloodstream Infections Due To Multidrug-Resistant Enterobacteriaceae: A Post-Hoc Analysis Of The Increment Study
(Elsevier Science Bv, 2017)
We describe regional differences in therapy for bloodstream infection (BSI) caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E) or carbapenemase-producing Enterobacteriaceae (CPE). Patients (n ...
High Prevalence Of Esbl-Producing Escherichia Coli And Klebsiella Pneumoniae In Community-Onset Bloodstream Infections In China
(Oxford Univ Press, 2017)
Objectives: Community-onset bloodstream infections (COBSIs) caused by ESBL-producing Escherichia coli (ESBLEC) and ESBL-producing Klebsiella pneumoniae (ESBL-KP) are increasing globally. This study aimed to investigate the ...
Emerging Problem Pathogens: A Review Of Resistance Patterns Over Time
(Elsevier Sci Ltd, 2006)
Despite the advances in chemotherapy for cancer patients, infectious complications remain an important cause of mortality and morbidity. Surveillance data report not only a shift in the aetiology of infections and resistance ...
A Multidisciplinary Team Approach to the Management of Patients with Suspected or Diagnosed Invasive Fungal Disease
(Oxford Univ Press, 2013)
Implementation of evidence-based guidelines for the treatment of invasive fungal disease (IFD) requires collaboration among numerous clinical and laboratory services, as partners in patient care. The multidisciplinary team ...
Risk Assessment and Prognostic Factors For Mould-Related Diseases in Immunocompromised Patients
(Oxford Univ Press, 2011)
Invasive fungal diseases are important causes of morbidity and mortality in immunocompromised patients. Patients with haematological malignancies and solid cancers, as well as those with allogeneic haematopoietic stem cell ...
Development And Validation Of The Increment-Esbl Predictive Score For Mortality In Patients With Bloodstream Infections Due To Extendedspectrum- Beta-Lactamase-Producing Enterobacteriaceae
(Oxford Univ Press, 2017)
Background. Bloodstream infections (BSIs) due to ESBL-producing Enterobacteriaceae (ESBL-E) are frequent yet outcome prediction rules for clinical use have not been developed. The objective was to define and validate a ...
Epidemiology Of Antimicrobial Resistance In Bloodstream Infections
(Taylor & Francis Inc, 2016)
Antimicrobial resistance in bacterial pathogens is a worldwide challenge leading high morbidity and mortality in clinical settings. Multidrug resistant patterns in gram-positive and -negative bacteria have resulted in ...
The Spectrum Of Diseases Causing Fever Of Unknown Origin In Turkey: A Multicenter Study
(Elsevier Sci Ltd, 2008)
Objective: The purpose of this trial was to determine the spectrum of diseases with fever of unknown origin (FUO) in Turkey. Methods: A prospective multicenter study of 154 patients with FUO in twelve Turkish tertiarycare ...
Ertapenem For The Treatment Of Bloodstream Infections Due To Esbl-Producing Enterobacteriaceae: A Multinational Pre-Registered Cohort Study
(Oxford Univ Press, 2016)
Objectives: Data about the efficacy of ertapenem for the treatment of bloodstream infections (BSI) due to ESBL-producing Enterobacteriaceae (ESBL-E) are Limited. We compared the clinical efficacy of ertapenem and other ...
Dali: Defining Antibiotic Levels In Intensive Care Unit Patients: Are Current Beta-Lactam Antibiotic Doses Sufficient For Critically Ill Patients?
(Oxford Univ Press, 2014)
Background. Morbidity and mortality for critically ill patients with infections remains a global healthcare problem. We aimed to determine whether beta-lactam antibiotic dosing in critically ill patients achieves concentrations ...